Surgical Innovations (SUN) AI Stock Analysis

• Market Cap: £4.20M
• Dividend Yield: N/A
• Average Volume (3M): 179.78K
• Price to Earnings (P/E): 77.7
• Beta (1Y): 0.05
• Revenue Growth: -4.98%
• EPS Growth: -114.29%
• Country: UK
• Employees: 80
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): N/A
• Shares Outstanding: 932,816,160
• 10 Day Avg. Volume: 43,249
• 30 Day Avg. Volume: 179,777
• PEG Ratio: >-0.01
• Price to Book (P/B): 0.60
• Price to Sales (P/S): 0.43
• P/FCF Ratio: -12.54
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 43 Neutral
• Price Target: 0.43 p ▼(-3.56% Downside)
• Action: Reiterated Date: 12/19/25
• Date: Action: Reiterated 12/19/25

The overall stock score of 43 reflects significant financial challenges, including declining revenue and negative profitability, which are the most impactful factors. Technical analysis indicates a bearish trend, further weighing on the score. Valuation is also a concern due to the negative P/E ratio and lack of dividend yield.

Positive Factors

Business Model Strength

The company's multi-faceted revenue model, including direct sales and strategic partnerships, supports long-term growth and market expansion.

Negative Factors

Revenue Decline

Declining revenue suggests difficulties in sustaining market demand, potentially impacting long-term financial performance.

Surgical Innovations Business Overview & Revenue Model

Company Description

Surgical Innovations (SUN) specializes in the development and manufacturing of advanced surgical instruments and devices, primarily focusing on minimally invasive surgical technologies. The company operates in the healthcare sector, providing inno...

Read more

Surgical Innovations (SUN) specializes in the development and manufacturing of advanced surgical instruments and devices, primarily focusing on minimally invasive surgical technologies. The company operates in the healthcare sector, providing inno...

How the Company Makes Money

Surgical Innovations generates revenue through the sale of its surgical instruments and devices to hospitals, surgical centers, and medical professionals. The company employs a multi-faceted revenue model that includes direct sales, distribution a...

Read more

Surgical Innovations generates revenue through the sale of its surgical instruments and devices to hospitals, surgical centers, and medical professionals. The company employs a multi-faceted revenue model that includes direct sales, distribution a...

Surgical Innovations Financial Statement Overview

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	11.91M	11.95M	12.01M	11.34M	9.13M	6.33M
Gross Profit	3.32M	3.44M	3.45M	3.92M	3.13M	1.27M
EBITDA	-771.00K	-99.00K	161.00K	628.00K	247.00K	-2.20M
Net Income	-1.44M	-1.94M	-509.00K	264.00K	-456.00K	-3.28M
Balance Sheet
Total Assets	11.50M	12.24M	14.32M	15.60M	15.72M	16.34M
Cash, Cash Equivalents and Short-Term Investments	-461.00K	195.00K	1.21M	2.20M	3.64M	5.28M
Total Debt	938.00K	1.24M	1.66M	2.16M	2.79M	3.27M
Total Liabilities	2.94M	3.70M	3.84M	4.63M	5.05M	5.25M
Stockholders Equity	8.56M	8.54M	10.48M	10.96M	10.66M	11.09M
Cash Flow
Free Cash Flow	159.00K	-409.00K	-288.00K	-592.00K	-1.09M	887.00K
Operating Cash Flow	214.00K	-74.00K	400.00K	486.00K	-433.00K	1.04M
Investing Cash Flow	-259.00K	-335.00K	-688.00K	-1.08M	-657.00K	-155.00K
Financing Cash Flow	-650.00K	-626.00K	-672.00K	-935.00K	-532.00K	3.15M

Surgical Innovations Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.45
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:SUN, the sentiment is Negative. The current price of 0.45 is above the 20-day moving average (MA) of 0.45, above the 50-day MA of 0.45, and below the 200-day MA of 0.57, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at <0.01 is Positive, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:SUN.

Surgical Innovations Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SN	70 Outperform	£10.30B	22.64	11.79%	2.35%	2.51%	56.56%
AMS	56 Neutral	£430.64M	47.21	3.87%	1.25%	68.03%	-18.27%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
CREO	48 Neutral	£44.86M	0.83	32.72%	―	―	―
SUN	43 Neutral	£4.20M	77.73	-16.78%	―	-4.98%	-114.29%

Surgical Innovations Corporate Events